Ledyard National Bank Eli Lilly & CO Transaction History

Ledyard National Bank

$1.09 Billion
Q3 2024

A detailed history of Ledyard National Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Ledyard National Bank holds 4,536 shares of LLY stock, worth $3.6 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

4,536

Previous 4,383 3.49%

Holding current value

$3.6 Million

Previous $3.97 Million 1.26%

% of portfolio

0.37%

Previous 0.39%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $118,137 - $146,883	153 Added 3.49%	4,536 $4.02 Million
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $351,561 - $440,884	485 Added 12.44%	4,383 $3.97 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $59,220 - $79,228	-100 Reduced 2.5%	3,898 $3.03 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $11,554 - $13,620	22 Added 0.55%	3,998 $2.33 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $8,694 - $11,986	20 Added 0.51%	3,976 $2.14 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $73,655 - $98,485	-210 Reduced 5.04%	3,956 $1.86 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $41,624 - $48,885	-134 Reduced 3.12%	4,166 $1.43 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $4,823 - $5,620	15 Added 0.35%	4,300 $1.57 Million
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $102,878 - $117,240	347 Added 8.81%	4,285 $1.39 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $1,393 - $1,636	5 Added 0.13%	3,938 $1.28 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $20,183 - $25,082	-86 Reduced 2.14%	3,933 $1.13 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $2,023 - $2,511	9 Added 0.22%	4,019 $1.11 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $40,804 - $52,780	-226 Reduced 5.34%	4,010 $920,000
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $18,568 - $24,037	113 Added 2.74%	4,236 $791,000
Q3 2020 Oct 21, 2020	SELL	$146.22 - $169.13 $62,143 - $71,880	-425 Reduced 9.34%	4,123 $610,000
Q2 2020 Jul 24, 2020	SELL	$136.42 - $164.18 $27,283 - $32,836	-200 Reduced 4.21%	4,548 $747,000
Q2 2019 Jul 26, 2019	SELL	$110.79 - $129.32 $24,927 - $29,097	-225 Reduced 4.52%	4,748 $526,000
Q1 2019 Apr 12, 2019	SELL	$111.31 - $131.02 $30,165 - $35,506	-271 Reduced 5.17%	4,973 $645,000
Q3 2018 Oct 24, 2018	BUY	$85.86 - $107.31 $2,661 - $3,326	31 Added 0.59%	5,244 $562,000
Q1 2018 Apr 16, 2018	BUY	$74.21 - $87.6 $59,367 - $70,080	800 Added 18.13%	5,213 $403,000
Q4 2017 Jan 30, 2018	BUY	$81.94 - $87.89 $737 - $791	9 Added 0.2%	4,413 $373,000
Q3 2017 Oct 10, 2017	BUY	$77.07 - $85.54 $339,416 - $376,718	4,404	4,404 $377,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.

Account

Ledyard National Bank Eli Lilly & CO Transaction History